MedTrace Logo

Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy

NCT06583343 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-06

No results posted yet for this study

Summary

The aim of this study is to investigate the effects of Botulinum Neurotoxin-A (BoNT-A) injection applied to spastic muscles on pain sensation and Selective Motor Control (SMC) in cases diagnosed with diplegic spastic Cerebral Palsy.

Conditions

  • Cerebral Palsy Spastic Diplegia

Interventions

DRUG

OnabotulinumtoxinA

Botulinum toxin injections were administered in appropriate doses to the spastic muscles of children with cerebral palsy.

OTHER

Conventional Physical Therapy

Conventional rehabilitation program; consisting of walking-balance exercises, range of motion exercises, stretching, and strengthening exercises, was provided for 1 hour, 5 days a week, totaling 30 sessions

Sponsors & Collaborators

  • Gaziosmanpasa Research and Education Hospital

    lead OTHER_GOV

Principal Investigators

  • Ebru Yılmaz Yalçınkaya · Gaziosmanpasa Research and Education Hospital

  • Ozan Baş · Gaziosmanpasa Research and Education Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-25
Primary Completion
2023-05-25
Completion
2024-04-25
FDA Drug
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06583343 on ClinicalTrials.gov